Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Introduction: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date.
Methods: We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI).
Results: 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5-92.9%), cough (57.6%, 95%CI 40.8-74.4%) and dyspnea (45.6%, 95%CI 10.9-80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0-30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7-51.8), 6.2% (95%CI 3.1-9.3) with shock. Some 13.9% (95%CI 6.2-21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR).
Conclusion: COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19.
Ashrafi A, Lin Y, Fong A, Islam J, Anderson T, Ganesan S Cancers (Basel). 2025; 17(5).
PMID: 40075704 PMC: 11898501. DOI: 10.3390/cancers17050857.
Lu S, Miao L, He Y, Luo J, Lin L, Liu Z Front Oral Health. 2025; 6:1527777.
PMID: 40052120 PMC: 11882545. DOI: 10.3389/froh.2025.1527777.
Ma L, Chee C, Amri S, Gao X, Wang Q, Wang N PeerJ. 2025; 13:e18952.
PMID: 39995991 PMC: 11849512. DOI: 10.7717/peerj.18952.
A novel method for detecting SARS-CoV-2 IgM and IgG based on the gold immune chromatography assay.
Yao X, Xu H, Du Q, Lu X, Wang Q Sci Rep. 2025; 15(1):4995.
PMID: 39929938 PMC: 11811196. DOI: 10.1038/s41598-025-89012-1.
Ertem E, Gursel M Cureus. 2024; 16(12):e75696.
PMID: 39677992 PMC: 11646645. DOI: 10.7759/cureus.75696.